Orthobiologics Market Size to grow by USD 2768 million between 2024-2028
According to a research report “ Orthobiologics Market” by Application (Spinal fusion, Reconstructive surgery, Trauma repair, Others) Product (Bone graft substitutes, Viscosupplementation, Stem cells) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 2768 million, at a CAGR of 7.75% during the forecast period. The global orthopedic market has experienced notable growth due to the rising prevalence of orthopedic disorders, particularly among the aging population. Factors such as sedentary lifestyles and unhealthy diets can disrupt the body's homeostasis, leading to complications like osteoarthritis. This condition, which primarily affects those aged 60 and above, can cause joint damage and stress on the knees, hips, and lower spine. With advanced healthcare standards and treatments, life expectancy has increased, resulting in a larger population susceptible to joint issues. Arthritis, trauma, back pain, and osteoporosis are the most prevalent joint problems worldwide..
Browse market data tables, figures, and in-depth TOC on “Orthobiologics Market” by Application (Spinal fusion, Reconstructive surgery, Trauma repair, Others) Product (Bone graft substitutes, Viscosupplementation, Stem cells) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Application, the Spinal fusion segment is projected to dominate the market size in 2024
In the realm of spinal surgery, orthobiologics have emerged as a game-changer in enhancing the efficacy of spinal fusion procedures. By attracting more cells to the fusion site, these advanced orthobiologic solutions stimulate bone formation and promote biological healing. Spinal issues such as deformities, weakness, instability, and herniated disks necessitate the need for spinal fusion procedures. Orthobiologics, through their ability to accelerate the healing process, offer significant advantages in such surgeries. The market demand for orthobiologics in spinal fusion is anticipated to grow robustly due to their proven benefits in improving surgical outcomes and patient recovery.
By Product, Bone graft substitutes segment is expected to hold the largest market size for the year 2024
The Orthobiologics Market encompasses innovative solutions that leverage natural biological processes to promote bone and tissue healing. These advanced therapies, including bone marrow aspirate concentrates, platelet-rich plasma, and stem cell treatments, offer significant clinical benefits. By harnessing the power of the body's own healing mechanisms, Orthobiologics are revolutionizing the treatment landscape for various orthopedic conditions, ultimately improving patient outcomes and driving business growth within the healthcare industry.
North America is forecasted to hold the largest market size by region in 2024
The Orthobiologics Market encompasses innovative solutions that leverage natural biological processes to promote musculoskeletal healing. These advanced therapies, including bone marrow aspirate concentrates, platelet-rich plasma, and stem cell treatments, offer significant benefits over traditional surgical interventions. By harnessing the power of the body's own regenerative capabilities, Orthobiologics are revolutionizing orthopedic care, delivering faster recovery times, reduced risk of complications, and improved patient outcomes.
The Orthobiologics Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Orthobiologics market encompasses a range of biological and synthetic products used in the treatment of various bone and soft tissue conditions. These include bone infections such as Osteomyelitis, bone tumors, and bone diseases. Orthobiologics also play a crucial role in the healing of injured muscles, tendons, ligaments, and fractures resulting from sports injuries or accidents. Orthopedic procedures, including bone grafting and fracture recovery, have been revolutionized by the use of allografts, Bone Morphogenetic Protein (BMP), Synthetic Orthobiologics, and Demineralized Bone Matrix. Viscosupplementation products are another type of Orthobiologic therapy used to treat conditions like Osteoarthritis. Biotechnology and regenerative medicine have significantly contributed to the development of advanced Orthobiologic therapies, including Stem cell therapy. The aging population and the increasing prevalence of musculoskeletal disorders make the Orthobiologics market a growing and promising field. In summary, the Orthobiologics market offers a range of innovative solutions for the treatment of bone and soft tissue injuries and diseases, from bone infections and fractures to tendon and ligament injuries. These therapies are transforming the way we approach orthopedic care and are expected to continue driving growth in the market.
Market Research Overview
Orthobiologics is a rapidly growing market encompassing a range of advanced materials and technologies used in the repair and regeneration of bone, cartilage, tendons, ligaments, and other soft tissues. This field includes cellular allografts, bone graft substitutes, bone morphogenetic proteins (BMPs), bone void fillers, antibiotics, biocomposites, and synthetic bone substitutes, among others. Applications span from maxillofacial and dental procedures to spinal fusion, orthopedic surgeries for bone fractures, bone lesions, traumas, osteomyelitis, bone infections, bone tumors, and bone diseases. Orthobiologics address clinical limitations of traditional treatments and offer solutions for injuries, fracture recovery, and degenerative conditions such as osteoporosis, proliferative osteoarthritis, and sports injuries. The geriatric population benefits significantly from these advanced therapies, with applications in ambulatory care centers, hospitals, and orthopedic clinics. Innovations in the field include bioactive coatings, viscosupplementation products, platelet rich plasma, stem cell therapy, and synthetic orthobiologics like demineralized bone matrix and hyaluronic acid derivatives. Biotechnology and regenerative medicine continue to drive advancements in this field, providing new hope for those suffering from musculoskeletal disorders.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
